Children’s COVID-19 and MIS-C Biomarker Study
No reliable biomarker for predicting COVID-19 and MIS-C severity was available until the Children’s Healthcare of Atlanta Pediatric Neurotrauma Lab serendipitously discovered elevated levels of plasma osteopontin, an inflammatory biomarker they use to follow traumatic brain injuries (TBI) and concussions, were also elevated in COVID-19 positive and MIS-C patients.